Equity Profile

STVN

Stevanato Group S.p.A.

Health CareLife Sciences Tools & Services$5.1B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Stevanato Group S.p.A. is a healthcare company specializing in life sciences tools and services, particularly in the production of glass vials and syringes for the pharmaceutical industry....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge financial health this quarter.

$0.15

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the healthcare sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STVN Q2-2026 Earnings Preview

Context

Company Snapshot

Stevanato Group S.p.A. is a healthcare company specializing in life sciences tools and services, particularly in the production of glass vials and syringes for the pharmaceutical industry. With a market cap of $5 billion, it plays a crucial role in ensuring safe and effective delivery of medications, which is increasingly important as global healthcare demands grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+4.93%

Avg Stock Reaction

+4.40%

Last Quarter Recap

In Q1-2026, Stevanato reported an EPS of $0.13, slightly beating expectations. However, the stock fell 5.11% the following day, indicating market skepticism despite the earnings beat.

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to expanding product offerings in the life sciences sector.
Plans to enhance customer relationships and service delivery.

Expectations

Wall Street Expectations

Overall, expectations are mixed as Stevanato has shown a tendency to beat EPS estimates but has not consistently translated those beats into positive stock performance.

Bull Case

If the company can demonstrate strong revenue growth and maintain or improve its gross margins, it could lead to a positive stock reaction.

Bear Case

Conversely, if revenue growth is weak or margins decline, it could reinforce concerns about the company's ability to manage costs and compete effectively.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.15

EPS is a key indicator of the company's profitability and will help gauge financial health this quarter.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the healthcare sector.

Gross Margin

N/A

Gross margin will indicate how efficiently the company is managing its production costs relative to sales.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's $0.13?

A significant increase in EPS could signal improved profitability and operational efficiency, which the market will closely watch.

How is revenue growth trending in comparison to previous quarters?

Investors will be keen to understand if the company is successfully capturing market demand and expanding its customer base.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Stevanato's potential for revenue growth, particularly if the company successfully expands its product offerings.

Supporting Evidence

The company's recent operational improvements may not be fully reflected in current EPS estimates.

Options pricing suggests a significant move, indicating that traders expect more volatility than the consensus anticipates.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will reflect the company's ability to navigate market challenges and capitalize on growth opportunities.

Bull Confirmed If

An EPS of $0.17 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.12 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±27.3%

Historical Avg

±8.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±34.1% while STVN has averaged ±8.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.1%

Calls (300)P/C Ratio: 0.11Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 30 (47%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 30 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.6%, with a raw directional average of +2.5% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stevanato beats expectations and raises guidance, history suggests a positive stock reaction, with an average 1-day move of +1.1%.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may experience muted movement as investors digest the commentary.

Miss

If the company misses EPS expectations, history suggests a larger downside move, averaging around +13.55% in the past.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or partnerships in the life sciences sector.
2Insights into operational efficiencies and cost management strategies.
3Details on customer demand trends and market share growth.
4Management's outlook on future revenue growth and profitability.
5Responses to market challenges and competitive pressures.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Stevanato Group S.p.A. is a healthcare company specializing in life sciences tools and services, particularly in the production of glass vials and syringes for the pharmaceutical industry....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge financial health this quarter.

$0.15

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the healthcare sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+4.93%

Avg Stock Reaction

+4.40%

Last Quarter Recap

In Q1-2026, Stevanato reported an EPS of $0.13, slightly beating expectations. However, the stock fell 5.11% the following day, indicating market skepticism despite the earnings beat.

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to expanding product offerings in the life sciences sector.
Plans to enhance customer relationships and service delivery.

Expectations

Wall Street Expectations

Overall, expectations are mixed as Stevanato has shown a tendency to beat EPS estimates but has not consistently translated those beats into positive stock performance.

Bull Case

If the company can demonstrate strong revenue growth and maintain or improve its gross margins, it could lead to a positive stock reaction.

Bear Case

Conversely, if revenue growth is weak or margins decline, it could reinforce concerns about the company's ability to manage costs and compete effectively.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.15

EPS is a key indicator of the company's profitability and will help gauge financial health this quarter.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet increasing demand in the healthcare sector.

Gross Margin

N/A

Gross margin will indicate how efficiently the company is managing its production costs relative to sales.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's $0.13?

A significant increase in EPS could signal improved profitability and operational efficiency, which the market will closely watch.

How is revenue growth trending in comparison to previous quarters?

Investors will be keen to understand if the company is successfully capturing market demand and expanding its customer base.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Stevanato's potential for revenue growth, particularly if the company successfully expands its product offerings.

Supporting Evidence

The company's recent operational improvements may not be fully reflected in current EPS estimates.

Options pricing suggests a significant move, indicating that traders expect more volatility than the consensus anticipates.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will reflect the company's ability to navigate market challenges and capitalize on growth opportunities.

Bull Confirmed If

An EPS of $0.17 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $0.12 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±27.3%

Historical Avg

±8.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±34.1% while STVN has averaged ±8.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.1%

Calls (300)P/C Ratio: 0.11Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 30 (47%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stevanato beats expectations and raises guidance, history suggests a positive stock reaction, with an average 1-day move of +1.1%.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may experience muted movement as investors digest the commentary.

Miss

If the company misses EPS expectations, history suggests a larger downside move, averaging around +13.55% in the past.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or partnerships in the life sciences sector.
2Insights into operational efficiencies and cost management strategies.
3Details on customer demand trends and market share growth.
4Management's outlook on future revenue growth and profitability.
5Responses to market challenges and competitive pressures.